Please login to the form below

Not currently logged in
Email:
Password:

Acquisition strengthens Ketchum’s Southern US presence

North Carolina-based Capstrat offers corporate public affairs

Global communications consultancy Ketchum has acquired North Carolina-based healthcare, energy and technology public affairs agency Capstrat.

The move strengthens Ketchum's presence in the Southern US, while providing Capstrat with a greater diversity of services for multinational clients.

Capstrat will join the public affairs network, which currently has offices in Washington, DC, New York, London, Brussels, Madrid, Berlin, Rome, Moscow, Mumbai and Hong Kong.

"This acquisition is another important milestone in Ketchum's strategic growth plan," explained Rob Flaherty, CEO of Ketchum.

"We are excited to bring our two firms together to meet clients' business objectives. Through our partnership with Capstrat, we are not only adding expertise, but more importantly, we are adding incredible talent to the agency."

The agency, which offers creative, social media and analytics services to clients including GlaxoSmithKline, UNC Health Care and Quintiles, will continue to operate under its current brand, led by CEO and founder Ken Eudy.

"Ken and his leadership team have built a successful agency focused on blending strategy and creativity, attracting and growing the best talent, building longstanding client relationships through superior service, and a deep commitment to corporate social responsibility," said Rob Lorfink, president and chief operating officer of Ketchum.

Commenting on the acquisition, Eudy said: "This is an exciting time for Capstrat. I see great potential for our clients and colleagues, as we become part of the Ketchum network. Our stakeholders will benefit from the depth of talent, extraordinary commitment to employee development, and broad geographic reach that Ketchum offers. I can't wait to be an active contributor to the network, as well."

15th January 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics